MedTrace Logo

Lean Body Weight-adjusted Rocuronium Dose and Intubation Conditions

NCT05476952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2023-09-28

No results posted yet for this study

Summary

In this study, researchers wiil administer rocuronium, based on either the lean body weight or the total body weight in patients with body mass index (BMI) of 18.5 to 34.9 and compared the duration of action of the drug and its effects on tracheal intubation conditions and hemodynamic parameters..

Conditions

  • Body Weight Changes
  • Rocuronium
  • Intubation Conditions

Interventions

PROCEDURE

he patients who are administered rocuronium according to LBW were categorized as "LBW", and The group number for those administer according to TBW was categorized as "K".

Patients will be divided equally and validly by the one who will be placed in opaque sealed envelopes on a self-paid basis. One group will be given 0.6 mg/kg rocuronium on an LBW basis (Curon ® 50 mg/5 mL \[Mustafa Nevzat, Istanbul, Turkey\]), and the other group will be given 0.6 mg/kg rocuronium on a TBW basis.

Sponsors & Collaborators

  • Inonu University

    collaborator OTHER

  • DUYGU DEMİROZ

    lead OTHER

Principal Investigators

  • duygu demiröz · INONU UNİVERSİTY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2023-03-18
Completion
2023-04-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476952 on ClinicalTrials.gov